Diaceutics Plc
2.31
USD
+0.31
(+15.30%)
Important Dates
Diaceutics PLC's next confirmed earnings release is scheduled for March 15, 2027.
| Earnings Date | 3/15/2027 |
Share Statistics
As of December 31, 2025, Diaceutics PLC has 84.61M shares outstanding.
| Shares Outstanding | 84.61M |
Financial Position
As of December 31, 2025, Diaceutics PLC maintains a current ratio of 3.43, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.43 |
| Quick Ratio | 0.86 |
| Debt / Equity | 2.85 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 202.00 |
Stock Price Statistics
As of the close on September 23, 2026, Diaceutics PLC's stock has gained approximately 68.67% over the past 52 weeks.
| 52-Week Price Change | 68.67% |
Balance Sheet
USDAs of December 31, 2025, Diaceutics PLC holds 9.90M in cash and equivalents against 1.55M in total debt, resulting in a net debt position of -9.90M. Total book value stands at 54.54M, with working capital of 28.04M providing operational flexibility.
| Cash & Cash Equivalents | 9.90M |
| Total Debt | 1.55M |
| Net Debt | -9.90M |
| Equity (Book Value) | 54.54M |
| Book Value Per Share | 0.64 |
| Working Capital | 28.04M |